Grupp U, Siebert G
Res Exp Med (Berl). 1978 Sep 25;173(3):261-78. doi: 10.1007/BF01851498.
Hydrogenated palatinose, an equimolar mixture of alpha-D-glucopyranosido-1,6-sorbitol and alpha-D-glucopyranosido-1,6-mannitol, was investigated as a potential oral sugar substitute in the following experiments in man and rat. 1. Enzymatic cleavage occurred at slow rates by maltase (alpha-glucosidase) of jejunal mucosa, liver lysosomes and yeast. 2. Part of ingested hydrogenated palatinose arrived unsplit at the caecum of the rat and underwent fermentation there; excretion in feces and urine are neglegible in man and rat. 3. Growth and maintenance of rats demonstrated 20--40 percent diminished caloric utilisation of diets containing 34.5 percent hydrogenated palatinose whereas indirect calorimetry in man showed about 50 percent caloric deficit. 4. Blood sugar did not increase in man after oral doses up to 100 g. 5. The capacity of the rat kidneys for excretion of hydrogenated palatinose and its constituents was high, symptoms of incompatibility were not observed.
氢化帕拉金糖是α-D-吡喃葡萄糖苷-1,6-山梨醇和α-D-吡喃葡萄糖苷-1,6-甘露糖醇的等摩尔混合物,在以下人体和大鼠实验中作为一种潜在的口服糖替代品进行了研究。1. 空肠黏膜、肝溶酶体和酵母中的麦芽糖酶(α-葡萄糖苷酶)以缓慢的速率对其进行酶解。2. 摄入的部分氢化帕拉金糖未被分解就到达大鼠盲肠并在那里发酵;在人和大鼠中,其粪便和尿液排泄量可忽略不计。3. 大鼠的生长和维持表明,含有34.5%氢化帕拉金糖的日粮的热量利用率降低了20%至40%,而人体间接测热法显示热量赤字约为50%。4. 人体口服高达100克的剂量后,血糖没有升高。5. 大鼠肾脏排泄氢化帕拉金糖及其成分的能力很高,未观察到不相容症状。